These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 8865269
41. HLA-DR, -DQB typing of steroid-sensitive idiopathic nephrotic syndrome children in Taiwan. Huang YY, Lin FJ, Fu LS, Lan JL. Nephron Clin Pract; 2009; 112(2):c57-64. PubMed ID: 19390203 [Abstract] [Full Text] [Related]
42. Levamisole as immunostimulant in the clinical practice. Pár A. Ther Hung; 1983; 31(4):161-71. PubMed ID: 6546263 [No Abstract] [Full Text] [Related]
43. Side effects of levamisole in children with nephrosis. Palcoux JB, Niaudet P, Goumy P. Pediatr Nephrol; 1994 Apr; 8(2):263-4. PubMed ID: 8018513 [No Abstract] [Full Text] [Related]
44. Autoimmune thyroiditis in a child with steroid-dependent nephrotic syndrome. Tasic V, Angjeleska M, Ristoska-Bojkovska N, Petrusevska G, Gucev Z. Eur J Pediatr; 2009 Feb; 168(2):229-31. PubMed ID: 18461358 [Abstract] [Full Text] [Related]
45. Liver toxicity in a nephrotic patient treated with levamisole. Bulugahapitiya DT. Arch Dis Child; 1997 Mar; 76(3):289. PubMed ID: 9135277 [No Abstract] [Full Text] [Related]
46. Treatment of partially corticosteroid-sensitive nephrotic syndrome with levamisole. Mancini ML, Rinaldi S, Rizzoni G. Pediatr Nephrol; 1994 Dec; 8(6):788. PubMed ID: 7696130 [No Abstract] [Full Text] [Related]
47. [The first experience of using membranotropic agents in the treatment of the nephrotic syndrome]. Ignatova MS, Moskaleva ES, Kopyleva SD, Katysheva OV. Ter Arkh; 1991 Dec; 63(6):122-5. PubMed ID: 1948728 [Abstract] [Full Text] [Related]
48. Levamisole Induced Agranulocytosis in a Child with Steroid Dependent Nephrotic Syndrome: A Case Report. Anjum MF, Gupta GK, Bhandari J. JNMA J Nepal Med Assoc; 2024 Jul 31; 62(276):545-547. PubMed ID: 39369404 [Abstract] [Full Text] [Related]
49. [Efficacy of BCG-PSN in the prevention of recurrence of nephritic syndrome in children]. Liu SG, Feng YG, Wang HY. Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jan 31; 12(1):68-9. PubMed ID: 20113641 [No Abstract] [Full Text] [Related]
50. [Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children]. Norero C, Delucchi A, Lagos E, Rosati P. Rev Med Chil; 1996 May 31; 124(5):567-72. PubMed ID: 9035508 [Abstract] [Full Text] [Related]
51. Enalapril: antiproteinuric effect in children with nephrotic syndrome. Lama G, Luongo I, Piscitelli A, Salsano ME. Clin Nephrol; 2000 Jun 31; 53(6):432-6. PubMed ID: 10879662 [Abstract] [Full Text] [Related]
52. Effect of lisinopril on proteinuria in children with nephrotic syndrome in Ilorin, Nigeria. Adedoyin OT, Ologe MO, Anigilaje EA, Adeniyi A. Pediatr Nephrol; 2003 Jul 31; 18(7):727-8. PubMed ID: 12734747 [No Abstract] [Full Text] [Related]
53. Nephrotic syndrome in two members of a family with mercury poisoning. Meeks A, Keith PR, Tanner MS. J Trace Elem Electrolytes Health Dis; 1990 Dec 31; 4(4):237-9. PubMed ID: 2136288 [Abstract] [Full Text] [Related]
54. Interferon-beta: a novel way to treat nephrotic syndrome? Rees AJ, Kain R. J Am Soc Nephrol; 2007 Nov 31; 18(11):2797-8. PubMed ID: 17942945 [No Abstract] [Full Text] [Related]
55. Predictors of relapse in steroid-sensitive nephrotic syndrome. Noer MS. Southeast Asian J Trop Med Public Health; 2005 Sep 31; 36(5):1313-20. PubMed ID: 16438164 [Abstract] [Full Text] [Related]
56. Onset of leukaemia after levamisole treatment for nephrotic syndrome. Mackie FE, Roy LP, Stevens M. Pediatr Nephrol; 1994 Aug 31; 8(4):527-8. PubMed ID: 7947054 [No Abstract] [Full Text] [Related]
57. Management strategy for idiopathic nehprotic syndrome in children. Chiu MC. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan 31; 33(1):1-7. PubMed ID: 18245896 [Abstract] [Full Text] [Related]
58. [Recurrent otitis in infants and small children of a children's community. Etiopathogenic, diagnostic and therapeutic aspects]. Szöcs A. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1984 Jan 31; 29(2):115-21. PubMed ID: 6235541 [No Abstract] [Full Text] [Related]
59. Immunocompetent cells and lymphocyte reactivity to mitogens in levamisole-treated brain tumor children. Hajnzić TF, Kastelan M, Lukac J, Hajnzić T. Pediatr Hematol Oncol; 1999 Jan 31; 16(4):335-40. PubMed ID: 10407870 [Abstract] [Full Text] [Related]
60. Levamisole as an immunostimulant. Pár A. Ther Hung; 1980 Jan 31; 28(4):163-7. PubMed ID: 6782693 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]